期刊文献+

内镜化疗粒子植入缓解晚期食管癌梗阻症状的临床研究 被引量:4

Endoscopyic implantation of slow-releasing 5-fluorouracil in relieving malignant esophagus obstruction
下载PDF
导出
摘要 目的对16例晚期食管癌导致的食管管腔梗阻患者行内镜下缓释5-氟尿嘧啶(5-FU)粒子植入治疗,观察其缓解梗阻的疗效。方法胃镜下对食管癌梗阻部结节及浸润处多点或密集型植入5-FU缓释粒子。结果 16例患者施行粒子植入治疗后,缓解梗阻有效14例,无效2例,总有效率87.5%。内镜下缓释5-FU粒子植入治疗未发生出血、穿孔等并发症及恶心、呕吐、腹痛、发热等不良反应,肝、肾功能及血常规检查未见异常。结论内镜下缓释5-FU粒子植入治疗是缓解晚期食管癌患者梗阻症状安全、有效的方法。 Objective To observe the efficacy of endoscopic implantation of slow-releasing 5-fluorouracil (5-FU) in relieving esophagus obstruction due to locally-advance carcinoma. Methods A total of 16 advanced esophagus cancer patients were enrolled into this study. During the endoscopy procedure, slow-releasing 5-FU agent was implanted compactly into the infiltrated tumor lesion. Results After endoscopy procedure, the numbers of patients with effective resuits in relieving symptom were 14, with overall response rate of 87.5%. Hemorrhage, perforation, nausea, vomit, abdominal pain, fever were not observed. Parameters of hepato-renal function and complete blood count were stable after implantation. Conclusion Endoscopic implantation of slow-releasing 5-fluorouracil is safe and effective in relieving ma- lignant esophagus obstruction.
机构地区 泰安市中心医院
出处 《胃肠病学和肝病学杂志》 CAS 2011年第10期907-908,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 食管癌 5-氟尿嘧啶 内镜植入 Esophagus carcinoma 5-fluorouraeil Endoscopic implantation
  • 相关文献

参考文献5

二级参考文献18

  • 1吕孝鹏,孙新臣,孙临飞,权斌,刘鹏.术中放射性^(125)I粒子植入在不可切除的胰腺癌中的应用[J].肿瘤防治杂志,2004,11(12):1312-1314. 被引量:9
  • 2金震东,李兆申,刘岩,杜奕奇,王洛伟,湛先保,陈洁.超声内镜引导下定向植入放射性^(125)I粒子治疗胰腺癌的临床研究[J].中华消化内镜杂志,2006,23(1):15-18. 被引量:53
  • 3吴云林,陈丽娜,吴巍,慎睿哲,陆玮,马文芳,蒋慧,陈颖.内镜化疗粒子植入缓解进展期胃癌梗阻症状观察[J].内科理论与实践,2007,2(4):265-267. 被引量:21
  • 4周福润.胃癌的内镜治疗//刘倩,王文奇.毛海婷.胃癌.北京:人民卫生出版社,2004:450-460.
  • 5陈红专.抗恶性肿瘤药物//杨世杰.药理学.北京:人民卫生出版社.2002:141-154.
  • 6朱舜时.胃肿瘤//萧树东.江绍基胃肠病学.上海科学技术出版社,2000:648-661.
  • 7Watanabe M,Kida M,Yamada Y,et al.Measuring tumor volume with three-dimensional endoscopic ultrasonography:an experimental and clinical study(including video).Endoscopy,2004,36:976-981.
  • 8Homs MY,Steyerberg EW,Eijkenboom WM,et al.Single-dose brachy therapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer:multicentre randomised trial[J].Lancet,2004,364(9444):1497-1504.
  • 9Frimberger E.Expanding spiral-a new type of prosthesis for the palliative treatment of malignant esophageal stenoses[J].Endoscopy,1983,15(Suppl 1):213-214.
  • 10Holm HH,Stroyer I,Hansen H,et al.Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy.Br J Radiol,1981,54:665-670.

共引文献92

同被引文献39

  • 1茹甫毅,牛明华,赵琪,姜海行,李延军.食管癌放疗前植入化疗缓释粒子35例疗效观察[J].现代肿瘤医学,2008,16(11):1920-1921. 被引量:9
  • 2SONG Z, ZHONG Y. Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma[J]. Onco Targets Ther, 2014, 13(7): 1875-1881.
  • 3TIAN GY, M1U M, HUANG XE. Systematic analysis of peme- trexed-based chemoradiotherapy for patients with locally advanced or metastatic esophageal cancer [J]. Asian Pac J Cancer Prev, 2014, 15(19): 8475-8478.
  • 4AKUTSU Y, MATSUBARA H. Pre-and post operative chemother- apy for resectable esophageal cancer [J]. Gan To Kagaku Ryoho, 2014, 41(9): 1087-1090.
  • 5Japanese CHEN G, PENG J, ZHU W, et al. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing pa- clitaxel-based chemotherapy[J]. Med Oncol, 2014, 31(11): 263.
  • 6KILIC E, SCHILD SE, THORNS C, et al. Prognostic role of vascular endothelial growth factor and its receptor-1 in patients with esophageal cancer [J]. Anticancer Res, 2014, 34 (9):5221-5226.
  • 7LINDNER K, BORCHARDT C, SCHOPP M, et al. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic po- tential and chemotherapy resistance, and affect expression of re- sistance-relevant miRNAs in esophageal cancer [J]. J Exp Clin Cancer Res, 2014, 33(1): 73.
  • 8ROEDER F, NICOLAY NH, NGUYEN T, et al. Intensity mod- ulated radiotherapy (IMRT) with concun'ent chemotherapy as definitive treatment of locally advanced esophageal cancer [J]. Radiat Oneol, 2014, 29(9): 191.
  • 9HVID-JENSEN F, FUNCH JP, DREWES pump inhibitors, GERD and oesophageal AM. Letter: proton thor's reply[J]. Aliment Pharmaeol Ther, 2014, 40(3): 320.
  • 10JIANC, C, LIAO FX, RONG YM, et al. Eiticacy of tax- ane-based regimens in a first-line setting for recurrent and/or metastatic Chinese patients with esophageal cancer[J]. Asian Pac J Cancer Prey, 2014, 15(13): 5493-5498.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部